Anaplastic lymphoma receptor kinase (ALK) alterations have been identified in several human cancers, including neuroblastoma, glioblastoma, lung cancer, anaplastic large cell lymphoma, and renal cell carcinoma (Hallberg & Palmer, 2013). This evidence concerns the gene ALK and cancer.